Epidemiologic and diagnostic evaluation of a recent mumps outbreak using oral fluid samples

J Clin Virol. 2008 Feb;41(2):134-7. doi: 10.1016/j.jcv.2007.10.009.

Abstract

Objective: To determine the optimal strategy to investigate mumps virus infection in a partially vaccinated cohort.

Study design: 122 oral fluid and serum samples were collected in a recent outbreak in Ireland. The largest age cohort, students aged 18-21 years old attending third level institutions, were investigated using virus isolation, detection of mumps specific IgM, IgG, RT-PCR and molecular genotyping.

Results: 97% of patients had both detectable serum IgM and IgG. Mumps virus RNA was detected in 17 oral fluid samples and 14 of these originated from a single geographic location. Only 6 of the IgM positive samples had detectable mumps virus RNA whereas this could be detected in 11 IgM negative samples. Genotyping studies revealed that genotypes G and J were co-circulating during this outbreak.

Conclusions: The use of an oral fluid sample to detect mumps virus RNA and IgM offers a major improvement over serological diagnosis in acute infection in both non-vaccinated or partially vaccinated individuals, and has the advantage that specimens are collected non-invasively.

Publication types

  • Evaluation Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antibodies, Viral / analysis
  • Antibodies, Viral / blood
  • Child
  • Child, Preschool
  • Disease Outbreaks*
  • Female
  • Genotype
  • Humans
  • Immunoglobulin G / analysis
  • Immunoglobulin G / blood
  • Immunoglobulin M / analysis
  • Immunoglobulin M / blood
  • Infant
  • Ireland / epidemiology
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Mumps / diagnosis*
  • Mumps / epidemiology*
  • Mumps / prevention & control
  • Mumps / virology
  • Mumps Vaccine / administration & dosage
  • Mumps virus / classification
  • Mumps virus / genetics
  • Mumps virus / immunology*
  • Mumps virus / isolation & purification*
  • RNA, Viral / analysis
  • RNA, Viral / blood
  • Reverse Transcriptase Polymerase Chain Reaction
  • Saliva / immunology*
  • Saliva / virology*
  • Treatment Failure

Substances

  • Antibodies, Viral
  • Immunoglobulin G
  • Immunoglobulin M
  • Mumps Vaccine
  • RNA, Viral

Associated data

  • GENBANK/EU009862
  • GENBANK/EU009863
  • GENBANK/EU009864